Predictive factors of efficacy for FTD/TPI plus bevacizumab in refractory metastatic colorectal cancer patients: a subanalysis of the Spanish cohort from the SUNLIGHT phase III trial.

- Posted by

Read the original article on Pubmed


Please, help us continue to provide valuable information:

Useful Links

Quick Links

Get in Touch

Le Duzic, Hameau de la Goduçais, Le Minihic sur Rance, 35870, France

Contact the author